Movement Disorders · 2004 · 44 citations · 11 references
MedicineNeurologyNeuroscienceGlial BiologyNeurodegenerationNeuroimmunologyBrain ImagingFunctional NeuroimagingMicroglia BiologyNervous TissueNeuroinflammationPositron Emission TomographyBasal Ganglia LesionsCorticobasal SyndromeMicroglia ActivationMicroglial MetabolismMicroglial NeurodegenerationNeurologic Pet Imaging
Positron emission tomography (PET) using [(11)C]PK 11195, a ligand for peripheral benzodiazepine receptor binding sites, offers the opportunity to image activated microglia in vivo. This tool may therefore be used to display the occurrence of microglial activation in the course of neurodegeneration. A patient with the clinical diagnosis of corticobasal degeneration (CBD) and left-sided symptoms was studied using fluorodeoxyglucose (FDG) and [(11)C]PK 11195 PET. We found a marked right hemispheric hypometabolism and asymmetric microglial activation in corresponding areas of the basal ganglia and right temporal and parietal cortex. [(11)C]PK 11195 PET suggests involvement of microglial activation in the pathogenesis of CBD.
11
Virginia M.‐Y. Lee, Michel Goedert, John Q. Trojanowski · Annual Review of Neuroscience · 2001 · 2.4K citations
In-vivo measurement of activated microglia in dementia
Annachiara Cagnin, David J. Brooks, Angus Kennedy et al. · The Lancet · 2001 · 1.1K citations
Medicine, Neurology, Neuroscience +14
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Richard B. Banati, Jia Newcombe, Roger N. Gunn et al. · Brain · 2000 · 648 citations · Full text